The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Education & Experience:
Preferred Education and Experience:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including: More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
...Location New York, New York Shift: Day (United States of America) Description: Impact the Future of Radiation Oncology Physicist - Radiation Oncology - Full Time NewYork-Presbyterian Hospital is one of the nation's most comprehensive academic health...
...towards utilizing TopCourt as tennis' premier online instruction platform? Do you have the... ...tennis entertainment space?As a customer success manager, you will have the... ...to ensure they are successful using our services~Implement and manage reporting systems...
...Position Summary: Under the direction and supervision of the pathologist, the Pathologist Assistant (PA) is responsible for the examination, description, dissection of anatomic pathology specimens and assists with frozen sections and autopsy procedures. Supervise gross...
...What You Need To Know 2026 Summer Internship | Human Resources - Syosset, NY Who we are looking for: December 2026 or May 2027 graduates Dates of Summer Internship: May 18th July 31st, 2026 Internship Location: Syosset, NY Shape a remarkable future...
Who We Are: Texas Pride Fuels is an experienced full-service diesel and lubricant supplier to the oil and gas industry. We specialize in on-sitehydraulic fracturing (frac)service all over Texas, Oklahoma, and New Mexico. What You'll Do: The Lubricant Truck Driver...